Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer

Background: Total neoadjuvant therapy (TNT) is an accepted approach for the management of locally advanced rectal cancer (LARC) and is associated with a decreased risk of development of metastatic disease compared to standard neoadjuvant therapy. However, questions remain regarding surgical outcomes...

Full description

Bibliographic Details
Main Authors: I-Chia Liu, MD, Susan Gearhart, MD MEd, Suqi Ke, MS, Chen Hu, PhD MS, Haniee Chung, MD, Jonathan Efron, MD, Alodia Gabre-Kidan, MD MPH, Peter Najjar, MD MBA, Chady Atallah, MD, Bashar Safar, MD, Eric S. Christenson, MD, Nilofer S. Azad, MD, Valerie Lee, MD, Atif Zaheer, MD, Jacqueline E. Birkness-Gartman, MD, Abhinav V. Reddy, MD, Amol K. Narang, MD, Jeffrey Meyer, MD MS
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Surgery Open Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589845024000174
_version_ 1797226664774598656
author I-Chia Liu, MD
Susan Gearhart, MD MEd
Suqi Ke, MS
Chen Hu, PhD MS
Haniee Chung, MD
Jonathan Efron, MD
Alodia Gabre-Kidan, MD MPH
Peter Najjar, MD MBA
Chady Atallah, MD
Bashar Safar, MD
Eric S. Christenson, MD
Nilofer S. Azad, MD
Valerie Lee, MD
Atif Zaheer, MD
Jacqueline E. Birkness-Gartman, MD
Abhinav V. Reddy, MD
Amol K. Narang, MD
Jeffrey Meyer, MD MS
author_facet I-Chia Liu, MD
Susan Gearhart, MD MEd
Suqi Ke, MS
Chen Hu, PhD MS
Haniee Chung, MD
Jonathan Efron, MD
Alodia Gabre-Kidan, MD MPH
Peter Najjar, MD MBA
Chady Atallah, MD
Bashar Safar, MD
Eric S. Christenson, MD
Nilofer S. Azad, MD
Valerie Lee, MD
Atif Zaheer, MD
Jacqueline E. Birkness-Gartman, MD
Abhinav V. Reddy, MD
Amol K. Narang, MD
Jeffrey Meyer, MD MS
author_sort I-Chia Liu, MD
collection DOAJ
description Background: Total neoadjuvant therapy (TNT) is an accepted approach for the management of locally advanced rectal cancer (LARC) and is associated with a decreased risk of development of metastatic disease compared to standard neoadjuvant therapy. However, questions remain regarding surgical outcomes and local control in patients who proceed to surgery, particularly when radiation is given first in the neoadjuvant sequence. We report on our institution's experience with patients who underwent short-course radiation therapy, consolidation chemotherapy, and surgery. Methods: We retrospectively reviewed surgical specimen outcomes, postoperative complications, and local/pelvic control in a large cohort of patients with LARC who underwent neoadjuvant therapy incorporating upfront short-course radiation therapy followed by consolidation chemotherapy. Results: In our cohort of 83 patients who proceeded to surgery, a complete/near-complete mesorectal specimen was achieved in 90 % of patients. This outcome was not associated with the time interval from completion of radiation to surgery. Postoperative complications were acceptably low. Local control at two years was 93.4 % for all patients- 97.6 % for those with low-risk disease and 90.4 % for high-risk disease. Conclusion: Upfront short-course radiation therapy and consolidation chemotherapy is an effective treatment course. Extended interval from completion of short-course radiation therapy did not impact surgical specimen quality.
first_indexed 2024-03-08T11:26:20Z
format Article
id doaj.art-f56d4f51e4e94956af647a79a5ceec3e
institution Directory Open Access Journal
issn 2589-8450
language English
last_indexed 2024-04-24T14:28:30Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Surgery Open Science
spelling doaj.art-f56d4f51e4e94956af647a79a5ceec3e2024-04-03T04:27:17ZengElsevierSurgery Open Science2589-84502024-03-01184249Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancerI-Chia Liu, MD0Susan Gearhart, MD MEd1Suqi Ke, MS2Chen Hu, PhD MS3Haniee Chung, MD4Jonathan Efron, MD5Alodia Gabre-Kidan, MD MPH6Peter Najjar, MD MBA7Chady Atallah, MD8Bashar Safar, MD9Eric S. Christenson, MD10Nilofer S. Azad, MD11Valerie Lee, MD12Atif Zaheer, MD13Jacqueline E. Birkness-Gartman, MD14Abhinav V. Reddy, MD15Amol K. Narang, MD16Jeffrey Meyer, MD MS17Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Surgery, Colorectal Research Unit, Ravitch Division of Colorectal Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USADivision of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USADivision of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Surgery, Colorectal Research Unit, Ravitch Division of Colorectal Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Surgery, Colorectal Research Unit, Ravitch Division of Colorectal Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Surgery, Colorectal Research Unit, Ravitch Division of Colorectal Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Surgery, Colorectal Research Unit, Ravitch Division of Colorectal Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Surgery, Division of Colon and Rectal Surgery, NYU Langone Health, New York, NY, USADepartment of Surgery, Division of Colon and Rectal Surgery, NYU Langone Health, New York, NY, USADepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USADepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USADepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USADepartment of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Corresponding author at: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 401 North Broadway, Suite 1440, Baltimore, MD 21231, USA.Background: Total neoadjuvant therapy (TNT) is an accepted approach for the management of locally advanced rectal cancer (LARC) and is associated with a decreased risk of development of metastatic disease compared to standard neoadjuvant therapy. However, questions remain regarding surgical outcomes and local control in patients who proceed to surgery, particularly when radiation is given first in the neoadjuvant sequence. We report on our institution's experience with patients who underwent short-course radiation therapy, consolidation chemotherapy, and surgery. Methods: We retrospectively reviewed surgical specimen outcomes, postoperative complications, and local/pelvic control in a large cohort of patients with LARC who underwent neoadjuvant therapy incorporating upfront short-course radiation therapy followed by consolidation chemotherapy. Results: In our cohort of 83 patients who proceeded to surgery, a complete/near-complete mesorectal specimen was achieved in 90 % of patients. This outcome was not associated with the time interval from completion of radiation to surgery. Postoperative complications were acceptably low. Local control at two years was 93.4 % for all patients- 97.6 % for those with low-risk disease and 90.4 % for high-risk disease. Conclusion: Upfront short-course radiation therapy and consolidation chemotherapy is an effective treatment course. Extended interval from completion of short-course radiation therapy did not impact surgical specimen quality.http://www.sciencedirect.com/science/article/pii/S2589845024000174Rectal cancerRadiation therapyProctectomy
spellingShingle I-Chia Liu, MD
Susan Gearhart, MD MEd
Suqi Ke, MS
Chen Hu, PhD MS
Haniee Chung, MD
Jonathan Efron, MD
Alodia Gabre-Kidan, MD MPH
Peter Najjar, MD MBA
Chady Atallah, MD
Bashar Safar, MD
Eric S. Christenson, MD
Nilofer S. Azad, MD
Valerie Lee, MD
Atif Zaheer, MD
Jacqueline E. Birkness-Gartman, MD
Abhinav V. Reddy, MD
Amol K. Narang, MD
Jeffrey Meyer, MD MS
Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer
Surgery Open Science
Rectal cancer
Radiation therapy
Proctectomy
title Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer
title_full Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer
title_fullStr Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer
title_full_unstemmed Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer
title_short Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer
title_sort surgical and local control outcomes after sequential short course radiation therapy and chemotherapy for rectal cancer
topic Rectal cancer
Radiation therapy
Proctectomy
url http://www.sciencedirect.com/science/article/pii/S2589845024000174
work_keys_str_mv AT ichialiumd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT susangearhartmdmed surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT suqikems surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT chenhuphdms surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT hanieechungmd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT jonathanefronmd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT alodiagabrekidanmdmph surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT peternajjarmdmba surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT chadyatallahmd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT basharsafarmd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT ericschristensonmd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT nilofersazadmd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT valerieleemd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT atifzaheermd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT jacquelineebirknessgartmanmd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT abhinavvreddymd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT amolknarangmd surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer
AT jeffreymeyermdms surgicalandlocalcontroloutcomesaftersequentialshortcourseradiationtherapyandchemotherapyforrectalcancer